A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone in newly diagnosed AML patients who are not candidates for intensive therapy - Projekt - Autoren - KSSG Forschungsdatenbank

Projekt

A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone in newly diagnosed AML patients who are not candidates for intensive therapy

Laufend - Rekrutierung – laufend · 2024 bis 2028

Schittenhelm Marcus, Dei Cas Alissa

Schittenhelm, Marcus

Leitender Arzt
Ärztliche Leitung Ambulatorium Spital Linth
Medizinische Onkologie und Hämatologie · Dept. I

Dei Cas, Alissa

Medizinische Onkologie und Hämatologie · Dept. I